One billion doses of the Johnson & Johnson vaccine will be produced in India and distributed to Southeast Asian countries, with the help of the U.S., Japan, and Australia. The initiative, an output of the informal “Quad” alliance, is an attempt to counter Chinese vaccine diplomacy in the region.
The Chinese embassy in Australia shared a detailed list of 14 grievances that Beijing has against the country, extending far beyond China’s core interests and directly criticizing internal Australian affairs.
After months of vague accusations that Australia had broken “mutual trust” with China, Beijing has made explicit a list of grievances with the country.
U.S. Secretary of State Mike Pompeo met with his Japanese, Indian, and Australian counterparts in Tokyo today and urged the four countries to build a “true security framework” to “counter the challenge that the Chinese Communist Party presents.”
A long-anticipated hawkish turn in American strategy directed at the region around China — what Trump administration officials call the “Indo-Pacific,” because it sounds less Chinese...